Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro–in vivo evaluation

References

• Abbasoglu OE, Hosal BM, Sener B, Erdemoglu N, Gursel E. 2001. Penetration of topical fluconazole into human aqueous humor. Exp Eye Res. 72:147–151.
   PubMed Web of Science ®Google Scholar
• Abd-Elbary A, El-laithy HM, Tadros MI. 2008. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm. 357:189–198.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-gendy N. 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 9:740–747.
   PubMed Web of Science ®Google Scholar
• Aboofazeli R, Barlow DJ, Lawrence MJ. 2000. Particle size analysis of concentrated phospholipid microemulsions: II. Photon correlation spectroscopy. AAPS PharmSci. 2:1–10.
   Google Scholar
• Abraham MH, Hassanisadi M, Jalali-Heravi M, Ghafourian T, Cain WS, Cometto-Muniz JE. 2003. Draize rabbit eye test compatibility with eye irritation thresholds in humans: a quantitative structure–activity relationship analysis. Toxicol Sci. 76:384–391.
   PubMed Web of Science ®Google Scholar
• Abraham S, Furtado S, Bharath S, Basavaraj BV, Deveswaran R, Madhavan V. 2009. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm Sci. 22:175–179.
   PubMed Web of Science ®Google Scholar
• Abu Hashim II, El-dahan MS, Yusif RM, Abd-ElGawad AH, Arima H. 2014. Potential use of niosomal hydrogel as an ocular delivery system for atenolol. Biol Pharm Bull. 37:541–551.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. 2004. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol. 56:1509–1517.
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Kaur IP. 2005. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 290:155–159.
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Pal D, Mitra AK, Kaur IP. 2007. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int J Pharm. 338:21–26.
   PubMed Web of Science ®Google Scholar
• Ahmed I. 2003. The noncorneal route in ocular drug delivery. In: Mitra A, editor. Ophthalmic drug delivery systems. New York: Marcel Dekker; p. 335–363.
   Google Scholar
• Alany RG, Rade T, Nicoll J, Tucker IG, Davies NM. 2006. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Release. 111:145–152.
   PubMed Web of Science ®Google Scholar
• Alany RG, Tucker IG, Davies NM, Rades T. 2001. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm. 27:31–38.
   PubMed Web of Science ®Google Scholar
• Ambrosini A, Bossi G, Dante S, Dubinib G, Leone L, Bossi M, Zolese G. 1998. Lipid–drug interaction: thermodynamic and structural effects of antimicotic fluconazole on DPPC liposomes. Chem Phys Lipids. 95:37–47.
   Web of Science ®Google Scholar
• Arunothayanun P, Bernard MS, Craig DQ, Uchegbu IF, Florence AT. 2000. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm. 201:7–14.
   PubMed Web of Science ®Google Scholar
• Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. 2003. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 262:23–28.
   PubMed Web of Science ®Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, Donia AM. 2007. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech. 8:206–212.
   Web of Science ®Google Scholar
• Attwood D. 1994. Microemulsions. In: Colloidal drug delivery systems. New York: Marcel Dekker; p. 31–71.
   Google Scholar
• Azeem A, Ahmad FJ, Khan ZI, Talegaonkar S. 2008. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol. 29:723–730.
   Web of Science ®Google Scholar
• B. P. 2010. “British Pharmacopeia”. Vol. III, 6th ed. London: The Council of Europe: p. 3155–3157.
   Google Scholar
• Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. 1985. The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol. 37:863–868.
   PubMed Web of Science ®Google Scholar
• Bayindir ZS, Yuksel AN. 2010. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 99:2049–2060.
   PubMed Web of Science ®Google Scholar
• Behrens-Baumann W, Klinge B, Ruchel R. 1990. Topical fluconazole for experimental candida keratitis in rabbits. Br J Ophthalmol. 74:40–52.
   PubMed Web of Science ®Google Scholar
• Budai L, Hajdu M, Budai M, Grof P, Beni S, Noszal B, Klebovich I, Antal I. 2007. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int J Pharm. 343:34–40.
   PubMed Web of Science ®Google Scholar
• Burgess DS, Hastings RW, Summers KK, Hardin TC, Rinaldi MG. 2000. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans. Diagn Microbiol Infect Dis. 36:13–18.
   PubMed Web of Science ®Google Scholar
• Carafa M, Santucci E, Alhaique F, Coviello T, Murtas E, Riccieri FM, Lucania G, Torrisi MR. 1998. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm. 160:51–59.
   Web of Science ®Google Scholar
• Carafa M, Santucci E, Lucania G. 2002. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm. 231:21–32.
   PubMed Web of Science ®Google Scholar
• Chan J, El Maghraby GMM, Craig JP, Alany RG. 2007. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation. Int J Pharm. 328:65–71.
   PubMed Web of Science ®Google Scholar
• Cheruvu NPS, Amrite AC, Kompella UB. 2008. Effect of eye pigmentation on transscleral drug delivery. Invest Ophthalmol Vis Sci. 49:333–341.
   PubMed Web of Science ®Google Scholar
• Chhabra G, Chuttani K, Mishra AK, Pathak K. 2011. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm. 37:907–916.
   PubMed Web of Science ®Google Scholar
• Constantinides PP. 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 2:1561–1572.
   Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. 1991. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm Res. 8:1039–1043.
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sa `nchez A, Alonso MJ. 2001. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface application to cyclosporine A. Int J Pharm. 224:159–168.
   PubMed Web of Science ®Google Scholar
• Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. 2002. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci. 251:360–365.
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. 2006. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 308:140–148.
   PubMed Web of Science ®Google Scholar
• Fang J, Hong C, Chiu W, Wang Y. 2001. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm. 219:61–72.
   PubMed Web of Science ®Google Scholar
• Fetih G. 2016. Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Deliv Sci Technol. 35:8–15.
   Web of Science ®Google Scholar
• Foulks GN. 2007. Clinical evaluation of the efficacy of PEG/PG lubricant eye drops with gelling agent (HP-Guar) for the relief of the signs and symptoms of dry eye disease: a review. Drugs Today. 43:887–896.
   PubMed Web of Science ®Google Scholar
• Garrett ER, Carper RF. 1955. Prediction of stability in pharmaceutical preparations. I. Color stability in liquid multi-sulfa preparations. J Am Pharm Assoc. 44:515–518.
   Google Scholar
• Gaudana R, Jwala J, Boddu SHS, Mitra AK. 2009. Recent perspectives in ocular drug delivery. Pharm Res. 26:1197–1216.
   PubMed Web of Science ®Google Scholar
• Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. 2002. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm. 242:381–384.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 306:71–82.
   PubMed Web of Science ®Google Scholar
• Gupta A, Singh S, Kotla NG, Wester TJ. 2015. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine. 10:171–182.
   PubMed Web of Science ®Google Scholar
• Harris LG, Gwynn I, Richards RG. 1999. Contrast optimization for backscattered electron imaging of resin embedded cells. Scanning Microsc. 3:71–81.
   Google Scholar
• Higuchi T. 1963. Mechanism of rate of sustained-action medication: the theoretical analysis of rate of release of solid drug dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hurtado FK, Souza MJ, Melo JD, Rolim MBC. 2008. Microbiological assay and HPLC method for the determination of fluconazole in pharmaceutical injectable formulations. Lat Am J Pharm. 27:224–228.
   Web of Science ®Google Scholar
• Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N. 2009. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech. 10:1186–1192.
   PubMed Web of Science ®Google Scholar
• Jigar V, Puja V, Krutika S. 2011. Formulation and evaluation of topical niosomal gel of erythromycin. Int J Pharm Pharm Sci. 3:123–126.
   Google Scholar
• Kapoor Y, Chauhan A. 2008. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int J Pharm. 361:222–229.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. 2004. Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 269:1–14.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Manavathu EK, Chandrasekar PH. 2009. Aspergillus Flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses. 52:206–222.
   PubMed Web of Science ®Google Scholar
• Lang JC. 1995. Ocular drug delivery: conventional ocular formulations. Adv Drug Deliv Rev. 16:39–43.
   Web of Science ®Google Scholar
• Langevin D, Meunier J, Cazabat AM. 1985. Les microemulsions. La Recherche. 167:720–728.
   Google Scholar
• Lawrence MJ, Rees GD. 2000. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 45:89–121.
   PubMed Web of Science ®Google Scholar
• Leanpolchareanchai J, Padois K, Falson F, Bavovada R, Pithayanukul P. 2014. Microemulsion system for topical delivery of Thai mango seed kernel extract: development, physicochemical characterization and ex vivo skin permeation studies. Molecules. 19:17107–17129.
   PubMed Web of Science ®Google Scholar
• Liu H, Li S, Wang Y, Han F, Dong Y. 2006. Bicontinuous water-AOT/Tween85-isopropyl myristate microemulsion: a new vehicle for transdermal delivery of cyclosporine A. Drug Dev Ind Pharm. 32:549–557.
   PubMed Web of Science ®Google Scholar
• Lund W. 1994. Ophthalmic products. In: The pharmaceutical codex. 12th ed. London: The Pharmaceutical Press; p. 160–169.
   Google Scholar
• Lv FF, LI N, Zheng LQ, Tung CH. 2006. Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur J Pharm Biopharm. 62:288–294.
   PubMed Web of Science ®Google Scholar
• Lv FF, Zheng LQ, Tung CH. 2005. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm. 30:237–246.
   Google Scholar
• Mannermaa E, Vellonen KS, Urtti A. 2006. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev. 58:1136–1163.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. 2003. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces. 30:129–138.
   Web of Science ®Google Scholar
• Martin A, Bustamante P, Chun AHC. 1993. Kinetics. In: Physical pharmacy. 4th ed. Philadelphia: Lea and Febiger; p. 284–323.
   Google Scholar
• Martindale. 2014. “The Complete Drug References”. 38th ed. London, UK: Pharmaceutical Press; p. 578–581.
   Google Scholar
• Mehta SK, Kaur G, Bhasin KK. 2008. Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters. Pharm Res. 25:227–236.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Kaur G, Bhasin KK. 2010. Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies. J Pharm Sci. 99:1896–1911.
   PubMed Web of Science ®Google Scholar
• Missel PJ, Lang JC, Rodeheaver DP, Jani R, Chowhan MA, Chastain J, Dagnon T. 2009. Design and evaluation of ophthalmic pharmaceutical products. In: Florence AT, Siepmann J, editors. Modern pharmaceutics. U.S.: Informa Healthcare, Inc; p. 101–189.
   Google Scholar
• Panda A, Satpathy G, Nayak N, Kumar S, Kumar A. 2007. Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre. Clin Exp Ophthalmol. 35:44–50.
   PubMed Web of Science ®Google Scholar
• Patel A, Hammersmith K. 2008. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol. 19:302–306.
   PubMed Web of Science ®Google Scholar
• Pathak MK, Chhabra G, Pathak K. 2013. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm. 39:780–790.
   PubMed Web of Science ®Google Scholar
• Prabhu P, Nitish KR, Koland M, Harish N, Vijayanarayan K, Dhondge G, Charyulu R. 2010. Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system. J Young Pharm. 2:356–361.
   PubMedGoogle Scholar
• Pradhan R, Kim YI, Jeong JH, Choi HG, Yong CS, Kim JO. 2014. Fabrication, characterization and pharmacokinetic evaluation of doxorubicin-loaded water-in-oil-in-water microemulsions using a membrane emulsification technique. Chem Pharm Bull. 62:875–882.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. 1987. Simple equation for description of solute release: part 1, Fickian and non-Fickian release from nonswellable devices in the form of slab, spheres, cylinders or disk. J Control Release. 5:23–36.
   Google Scholar
• Sasaki H, Yamamura K, Mukai T, Nishida K, Nakamura J, Nakashima M, Ichikawa M. 2000. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle. Biol Pharm Bull. 23:1352–1356.
   PubMed Web of Science ®Google Scholar
• Schmalfusz U, Neubert R, Wohlrab W. 1997. Modification of drug penetration into human skin using microemulsions. J Control Release. 46:279–285.
   Web of Science ®Google Scholar
• Scholes PD, Coombes AGA, Illum L, Daviz SS, Vert M, Davies MC. 1993. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release. 25:145–153.
   Web of Science ®Google Scholar
• Seijo B, Fattal E, Roblot-Treupel L, Couvreur P. 1990. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int J Pharm. 62:1–7.
   Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. 2007. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 66:227–243.
   PubMed Web of Science ®Google Scholar
• Shukla PK, Kumar M, Keshava GB. 2008. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses. 51:183–199.
   PubMed Web of Science ®Google Scholar
• Sintzel MB, Bernatchez SF, Tabatabay C, Gurny R. 1996. Biomaterials in ophthalmic drug delivery. J Pharm Biopharm. 42:358–374.
   Google Scholar
• Soliman OA, Mohamed EA, El-Dahan MS, Khatera NA. 2017. Potential use of cyclodextrin complexes for enhanced stability anti-inflammatory efficacy, and ocular bioavailability of loteprednol etabonate. AAPS PharmSciTech.
   Web of Science ®Google Scholar
• Soliman OA, Mohamed EA, Khatera NA. 2016. In-situ gelling ophthalmic formulations for sustained release and enhanced ocular delivery of fluconazole. IOSR. 11:43–51.
   Google Scholar
• Tangri P, Khurana S. 2011. Basics of ocular drug delivery systems. Int J Res Pharm Biomed Sci. 2:1541–1552.
   Google Scholar
• Ti SE, Scott A, Janardhanan P, Tan DTH. 2007. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 143:755–762.
   PubMed Web of Science ®Google Scholar
• Tu J, Li P, Yang X, Pang H. 2005. HPLC determination of pirenzepine dihydrochloride in rabbit aqueous humor. J Chromatogr B Analyt Technol Biomed Life Sci. 822:300–303.
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 172:33–70.
   Web of Science ®Google Scholar
• Urbak SF, Degn T. 1994. Fluconazole in the management of fungal ocular infections. Ophthalmologica. 208:147–156.
   PubMed Web of Science ®Google Scholar
• Vandamme TF. 2002. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res. 21:15–34.
   PubMed Web of Science ®Google Scholar
• Vora B, Khopade AJ, Jain NK. 1998. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 54:149–165.
   PubMed Web of Science ®Google Scholar
• Winston PW, Bates DH. 1960. Saturated solutions for the control of humidity in biological research. Ecology. 41:232–237.
   Web of Science ®Google Scholar
• Yilmaz S, Ture M, Maden A. 2007. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 26:398–402.
   PubMed Web of Science ®Google Scholar
• Zeng W, Li Q, Wan T, Liu C, Pan W, Wu Z, Zhang G, Pan J, Qin M, Lin Y, et al. 2016. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces. 1:28–35.
   Google Scholar
• Zhou M, Donovan MD. 1996. Intranasal mucociliary clearance of putative bioadhesive polymer gels. Int J Pharm. 135:115–125.
   Google Scholar